Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer
Status:
Withdrawn
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies how well arsenic trioxide and itraconazole work in treating
patients with basal cell cancer that has spread to other places in the body and usually
cannot be cured or controlled with treatment. Drugs used in chemotherapy, such as arsenic
trioxide, work in different ways to stop the growth of tumor cells, either by killing the
cells, by stopping them from dividing, or by stopping them from spreading. Itraconazole may
help treat fungal infections in patients with basal cell cancer. Giving arsenic trioxide with
itraconazole may work better in treating basal cell cancer.